期刊文献+

Endostar体外稳定性研究 被引量:4

In vitro stability of Endostar
下载PDF
导出
摘要 目的:比较重组人内皮抑素恩度TM(EndostarTM)和毕赤酵母表达的内皮抑素(endostatin)在不同温度及不同pH条件下的稳定性,通过检测对内皮细胞的增殖抑制比较Endostar在4℃和37℃下的生物活性。方法:将Endostar和endostatin于4℃保存或37℃放置96 h后进行不同条件的聚丙烯酰胺凝胶电泳,比较Endostar和endostatin之间以及它们在不同温度放置后的电泳行为,采用兔源多克隆抗体进行Western blot验证。同时检测在两种温度下的Endostar对于人脐静脉内皮细胞HUVEC细胞增殖的抑制作用。结果:在还原性电泳中Endostar和endostatin在20 kD左右处均只出现一条带。在3种酸性非还原电泳条件下,endostatin出现明显的"smear"现象,无法观察到主要条带,Endostar在酸性不连续非还原电泳条件下只出现一条带,而在两种连续非还原电泳中虽然也出现"smear"现象,但是主要条带仍然存在,Endostar和en-dostatin在37℃放置96 h后与它们保存在4℃的样品相比,在各种电泳条件下有相似的电泳行为,Western blot验证了相应电泳的结果。在两种温度下的Endostar对于HUVEC的增殖抑制作用基本相同。结论:Endostar和endostatin具有相似的热稳定性,但在酸性条件下Endostar较endostatin更为稳定。 Aim:To compare the stability of EndostarTM and endostatin under different temperatures and pH using polyacrylamide gel electrophoresis(PAGE) and Western blot and to compare the activity of Endostar kept at 4 ℃ and 37 ℃ by inhibition of endothelial cell proliferation.Methods:Endostar and endostatin expressed by Phicha pastoris were kept at 4 ℃,and 37 ℃ for 96 hours,respectively.The electrophoresis of the samples was detected by reduced and non-reduced PAGE.The results were further confirmed by Western blot w...
出处 《中国药科大学学报》 CAS CSCD 北大核心 2009年第4期359-363,共5页 Journal of China Pharmaceutical University
关键词 非还原性电泳 恩度 ENDOSTATIN 重组人内皮抑素 稳定性 non-reducing SDS-PAGE Endostar endostatin recombinant human endostatin stability
  • 相关文献

参考文献3

二级参考文献10

  • 1杨林,王金万,汤仲明,刘秀文,黄镜,李树婷,董英,张和平,薛岚,储大同,孙燕.重组人血管内皮抑制素Ⅰ期临床研究[J].中国新药杂志,2004,13(6):548-553. 被引量:154
  • 2Kulke M, Bergsland E, Ryan DP, et al. A phase Ⅱ, open-label,safety, pharmacokinetic, and efficacy study of recombinant human endostatin in patients with advanced neuroendocrine tumors. Proc Am Soc Clin Oncol, 2003, 22: 239.
  • 3Fossella FV. Docetaxel in second-line treatment of non-small-cell lung cancer. Clin Lung Cancer, 2002, 3 (Suppl 2) :S23-28.
  • 4Dragomir ID, John FT, Audrey S, et al. Human paraoxonases (PONI, PON2, and PON3 ) are lactonases with overlapping and distinct substmte specificities[ J]. J Lipid Res, 2005, 46(6 ) : 1239 - 1247.
  • 5Mira R, Tony H, Khetam H, et al. Decreased maerephage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol[ J ]. Arterioscler Thromb Vasc Biol, 2004, 24( 1 ) : 175 - 180.
  • 6Carey JN, Noam B, Victor G, et al. Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins[J]. J Bio Chem, 2006, 281 (40) : 29491 -29500.
  • 7Robert AH, Philip WC, Stephen WS, et al. Paraoxonase-2 Gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus [J]. J Glin Endocrinol Metab, 1997, 82(10): 3373-3377.
  • 8Carey JN, David JW, Aditya G, et al. Paraoxonase-2 is a ubiquitously expressed protein with anfioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein [J]. J Bio Chem, 2001,276(48) :44444 - 44449.
  • 9Sergei NP, William C. When timing is everything: role of cell cycle regulation in asymmetric division[J]. Semin Cell Dev Biol, 2005, 16 (3) : 423 -437.
  • 10王金万,杨林.血管内皮抑制素及其临床研究进展[J].医学临床研究,2003,20(10):778-781. 被引量:3

共引文献147

同被引文献18

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部